MedTrace Logo

Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma

NCT07508098 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-02

No results posted yet for this study

Summary

study was conducted on middle aged male and female, including families and health care professional also.

Conditions

  • Melasma (Facial Melasma)

Interventions

DRUG

Triple combination cream

4.7% N-acetylcysteine, 2% Hydroquinone and 0.1 % triamcinolone acetate twice daily for 8 weeks

DRUG

Hydroquinone 4% Cream

twice daily for 8 weeks

Sponsors & Collaborators

  • Pak Emirates Military Hospital

    lead OTHER

Principal Investigators

  • QAMMAR khan DR, MBBS. FCPS(Dermatalogy) · Pak Emirates Military Hospital

  • Moizza tHAIR Dr, MBBS.FCPS(Dermatology) · Pak Emirates Military Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-18
Primary Completion
2026-01-19
Completion
2026-01-19
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07508098 on ClinicalTrials.gov